Login / Signup

Temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in European adults with and without diabetes.

Anna Meta Dyrvig KristensenManan PareekKristian Hay KragholmChristian Torp-PedersenJohn William McEvoyEva Irene Bossano Prescott
Published in: European journal of preventive cardiology (2023)
Aspirin therapy for primary prevention of CVD has decreased over the last two decades. However, the drug remained used in individuals with and without diabetes and a large proportion of individuals started on aspirin therapy had no CVD risk factors.
Keyphrases